YpsoLoop – Uniting patient convenience with circular design
YpsoLoop is designed with circularity in mind. It provides the convenience of a prefilled, two-step, single-use device, featuring two mono-material sub-assemblies intended to support automated disassembly and facilitate recycling processes.¹ All of this is backed by integration into your existing supply chain.
YpsoLoop Product Movie
The multi-award winning platform
Circularity starts with design Addressing material use and end-of-life considerations through circular design features
Achieving circularity in healthcare is a shared responsibility that requires collaboration across the entire value chain. Device manufacturers, pharma companies, supply chain partners, and patients all play key roles.
With YpsoLoop, we address material use and end-of-life considerations challenges through circular design features:
- Two mono-material sub-assemblies, intended to support automated disassembly and recycling.1
- Innovative engineering, bio-circular material sourcing and ecodesign principles contribute to a lower material-related carbon footprint.2
- Designed to support future take-back and recycling programs, which we aim to develop together with partners across the ecosystem.1
Cutting-edge usability Supporting patient confidence
ClickGuide® technology
YpsoLoop is designed to improve therapy outcomes and patient satisfaction through a solution engineered for simple, reliable self-administration for patients and caregivers, with features that support reliable, comfortable self-administration and make initial instruction simple and effective.
Equipped with ClickGuide® technology, YpsoLoop provides continuous acoustic feedback during injection, helping users maintain the correct holding time, decreasing early-lift errors.
+1.4s longer intuitive holding time on average, achieved in formative usability studies3
Ergonomically shaped cap
The ergonomically shaped cap is designed to make cap removal easy, especially supporting those with reduced dexterity.
For pharma partners, these usability enhancements are designed to support patient confidence and correct handling, informed by internal usability testing. The platform’s consistent, proven design aims to make instruction and supervision straightforward for healthcare professionals, supporting safe use across diverse patient populations.
Supply chain compatibility Engineered to fit your process without rebuilding it
YpsoLoop is engineered to integrate with existing final assembly infrastructure, enabling partners to transition to a device platform incorporating circular design features and usability enhancements without disrupting operations or existing investments.
It supports industry-standard primary containers, satisfying all industry standards with broad design limits, and can be incorporated into existing autoinjector assembly lines, simplifying scale-up for global production and protecting previous investments.
Specifications Facts and figures
- Needle type½" or 8mm
- Primary containerStandard 11040-4 1 mL PFS, with cut flange or small round flange
- Fill volume0.1 – 1.14 mL
- DosingFixed, complete content
- Viscosity1-35 with ½”, 1-50 with 8 mm
- Needle diameter29G TW and larger
- Injection time<10s
- PFS needle shieldRigid
- Needle insertion depth5 – 8 mm
- FeedbackVisual and continuous clicking
- Needle type½” or 8 mm
- Primary containerStandard 11040-4 2.25 mL PFS, with cut flange or small round flange
- Fill volume0.2 – 2.25 mL
- DosingFixed, complete content
- Viscosity1-25 with ½”, 1-40 with 8 mm
- Needle diameter29G TW and larger
- Injection time<10s
- PFS needle shieldRigid
- Needle insertion depth5 – 8 mm
- FeedbackVisual and continuous clicking
1 Actual material recovery and recycling outcomes depend on the availability of suitable collection, disassembly and recycling systems and may vary by region. 2 A third-party reviewed life cycle assessment (LCA), conducted in June 2026 and comparing YpsoLoop 1mL with YpsoMate 1mL, indicates a lower carbon footprint for YpsoLoop 1mL within the assessed scope, assumptions and system boundaries. The difference is primarily attributable to the sourcing of bio-circular materials. For details on product carbon footprint, bio-circular material, and other sustainability-related information, please visit: www.ypsomed.com/sustainability-services
3 Continuous clicking and holding time, Ypsomed human factors study, 2024
Disclaimer: The possibility of recycling depends on suitable collection, disassembly and recycling systems being available.
Explore the future
Are you ready for the newest autoinjector platform designed with circularity in mind that supports you in responding to evolving market expectations for your injectable therapies?
Contact us to explore your project with YpsoLoop.
Resources & expert insights on YpsoLoop
